Article Details
Retrieved on: 2022-10-24 06:04:31
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
AstraZeneca's Imjudo (tremelimumab) in combination with Imfinzi (durvalumab) ... Executive Vice President, Oncology Business Unit, AstraZeneca, ...
Article found on: news.cision.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here